Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins https://www.moneycontrol.com/news/business/stocks/biocon-wockhardt-eris-to-double-insulin-output-as-global-drugmakers-scale-back-to-focus-on-glp-1-new-generation-insulins-13103010.html